+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety) Product (Readers, Kits) Technique, End-user, and Region - Forecast to 2026

  • ID: 5203877
  • Report
  • December 2021
  • Region: Global
  • 376 Pages
  • Markets and Markets

FEATURED COMPANIES

  • Abbott Laboratories
  • Access Bio, Inc.
  • Danaher Corporation
  • Hologic, Inc.
  • Perkinelmer Inc.
  • Quidel Corporation

The global lateral flow assays market is projected to reach USD 11.4 billion by 2026 from USD 9.6 billion in 2021, at a CAGR of 3.4% during the forecast period. The high prevalence of infectious diseases worldwide, rapid growth in the geriatric population, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices are the major factors driving the growth of this market. On the other hand, reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are the key restraints.




Kits & Reagents segment accounted for the largest share in the lateral flow assays market

Based on product type, the lateral flow assays market is segmented into kits & reagents and lateral flow readers. In 2020, kits & reagents accounted for the larger share of 87.5% of the global lateral flow assays market. The large share of this segment can be attributed to the increasing application of lateral flow kits & reagents for POC testing, the growing burden of chronic diseases, the increasing use of lateral flow kits in home care, and their convenience and ease of use. The lateral flow readers segment is bifurcated into digital/handheld readers and benchtop readers. This segment is expected to grow at a higher CAGR of 7.1% during the forecast period.


Clinical Testing segment is expected to witness the fastest growth in the forecast period

Based on applications, the lateral flow assays market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The clinical testing segment accounted for the largest share of 89.3% of the lateral flow assays market in 2020. The large share of this segment can be attributed to the rising prevalence of chronic diseases, growing pressure to reduce healthcare costs, and the increasing demand for patient-centric care.


Sandwich assays technique accounted for the largest share of lateral flow assays market in 2020

Based on technique, the lateral flow assay kits & reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays. The sandwich assays technique dominated the lateral flow assays market with a share of 70.9% in 2020. The large share of this segment can be attributed to its better assay sensitivity and specificity and its extensive applications in the measurement of critical analytes (such as cardiac and hepatitis markers).


Blood samples accounted for the largest share of lateral flow assays market in 2020

Based on sample type, the clinical testing lateral flow assays market is segmented into blood, urine, saliva, and other samples. Blood samples accounted for the largest market share of 55.9% in 2020. The use of blood samples in lateral flow tests for infectious diseases such as malaria, HIV, and syphilis; the rising awareness of rapid testing solutions; and easy detection of disease antibodies from blood samples are key factors driving the growth of this segment.


The hospitals & Clinics segment accounted for the largest share of lateral flow assays market in 2020

Based on end users, the lateral flow assays market is segmented into hospitals & clinics, diagnostic laboratories, home care settings, pharmaceutical & biotechnology companies, and other end users. The hospitals & clinics segment accounted for the largest market share of 37.6% in 2020. Technological advancements, the increasing adoption of point-of-care testing and growing patient inclination toward fast and early diagnosis are driving the growth of the hospitals & clinics segment. The COVID-19 pandemic has also increased the demand for point-of-care testing in professional healthcare settings, further driving the growth of this market in the forecast period.


North America accounted for the largest share of the lateral flow assays market in 2020

The North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 38.8% of the lateral flow assays market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. However, the APAC is expected to grow at the highest CAGR of 5.8% during the forecast period. The rapidly developing healthcare industry in China and India, growth in the aging population, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals & clinics to rural areas, the availability of low-cost labor for manufacturing, the presence of a favorable regulatory environment, and growing demand for home and POC testing are supporting market growth in the APAC. The current COVID-19 scenario and its high impact in the Asia Pacific (especially India) have also resulted in a high growth rate in the lateral flow assays market in this region.


Research Coverage

The market study covers the lateral flow assays market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product type, application by technique, by sample type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.


Some of the key players in the Lateral flow assays market are Abbott Laboratories (US), F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), BD (US), bioMérieux SA (France), Bio-Rad Laboratories (US), Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Quidel Corporation (US), and Merck KGaA (Germany).


A breakdown of the primary participants (supply-side) for the lateral flow assays market referred to for this report is provided below:

  • By Company Type: Tier 1 - 35%, Tier 2 - 20%, and Tier 3 - 45%
  • By Designation: C-level - 45%, Director-Level - 25%, and Others - 30%
  • By Region: North America - 36%, Europe - 26%, Asia-Pacific - 21%, Latin America - 10%, and Middle East & Africa - 7%

Key Benefits of Buying the Report

The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the lateral flow assays market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.


Frequently Asked Questions about the Global Lateral Flow Assays Market

What is the estimated value of the Global Lateral Flow Assays Market?

The Global Lateral Flow Assays Market was estimated to be valued at $9.6 Billion in 2021.

What is the growth rate of the Global Lateral Flow Assays Market?

The growth rate of the Global Lateral Flow Assays Market is 3.4%, with an estimated value of $11.4 Billion by 2026.

What is the forecasted size of the Global Lateral Flow Assays Market?

The Global Lateral Flow Assays Market is estimated to be worth $11.4 Billion by 2026.

Who are the key companies in the Global Lateral Flow Assays Market?

Key companies in the Global Lateral Flow Assays Market include Abbott Laboratories, Abcam plc, Abingdon Health, Access Bio, Inc., Becton, Dickinson and Company, Bio, Rad Laboratories, Inc., bioMérieux SA and Chembio Diagnostic Systems, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Access Bio, Inc.
  • Danaher Corporation
  • Hologic, Inc.
  • Perkinelmer Inc.
  • Quidel Corporation

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Category-Wise Inclusions and Exclusions in the Lateral Flow Assays Market
1.3 Market Scope
1.3.1 Markets Covered
Figure 1 Lateral Flow Assays Market Segmentation
Figure 2 Lateral Flow Assays Market, by Region
1.3.2 Years Considered for the Study
1.4 Currency
Table 1 Exchange Rates Utilized for Conversion to USD
1.5 Stakeholders
1.6 Summary of Changes


2 Research Methodology
2.1 Research Approach
Figure 3 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Data from Primary Sources
2.1.2.3 Breakdown of Primaries
Figure 4 Breakdown of Primary Interviews (Supply Side): by Company Type, Designation, and Region
2.2 Market Size Estimation
Figure 5 Market Size Estimation: Revenue Share Analysis (2020)
Figure 6 Supply-Side Analysis: Lateral Flow Assays Market (2020)
Figure 7 Approach 3: Demand-Side Approach, Based on the Malaria Lateral Flow Testing Market Size (2020)
Figure 8 Approach 4: Top-Down Approach
Figure 9 CAGR Projections: Supply-Side Analysis of the Lateral Flow Assays Market (2020)
2.3 Market Breakdown & Data Triangulation
Figure 10 Data Triangulation Methodology
2.4 Key Industry Insights
2.5 Limitations
2.5.1 Methodology-Related Limitations
2.6 Risk Assessment
2.7 Assumptions for the Study


3 Executive Summary
Figure 11 Lateral Flow Assays Market, by Product, 2021 vs. 2026 (USD Million)
Figure 12 Lateral Flow Assay Kits & Reagents Market, by Technique, 2021 vs. 2026 (USD Million)
Figure 13 Lateral Flow Assays Market, by Application, 2021 vs. 2026 (USD Million)
Figure 14 Clinical Testing Lateral Flow Assays Market, by Sample Type, 2021 vs. 2026 (USD Million)
Figure 15 Lateral Flow Assays Market, by End-user, 2021 vs. 2026 (USD Million)
Figure 16 Geographical Snapshot of the Lateral Flow Assays Market


4 Premium Insights
4.1 Lateral Flow Assays Market Overview
Figure 17 Rising COVID-19 Patient Population and Growth in the Prevalence of Infectious Diseases are Driving the Growth of the Lateral Flow Assays Market
4.2 Regional Mix: Lateral Flow Assays Market
Figure 18 APAC to Register the Highest CAGR of 5.8% During the Forecast Period
4.3 Asia-Pacific Lateral Flow Assays Market, by Application and Country
Figure 19 Clinical Testing Segment Accounted for the Largest Share in Asia-Pacific
4.4 Lateral Flow Assays Market: Geographical Growth Opportunities
Figure 20 China to Register Highest Growth Rates During the Forecast Period
4.5 Lateral Flow Assays Market: Developing vs Developed Countries
Figure 21 Developing Countries to Offer Higher Growth


5 Market Overview
5.1 Introduction
5.2 Market Dynamics: Impact Analysis
5.2.1 Drivers
5.2.1.1 High Prevalence of Infectious Diseases Across the Globe
Figure 22 Prevalence of Infectious Diseases Worldwide
Table 2 Prevalence of HIV Worldwide (2017 vs. 2020)
5.2.1.2 Rapidly Increasing Geriatric Population
Figure 23 Geriatric Population, by Region, 2020 vs. 2050 (Million)
Figure 24 Geriatric Population, by Country, 2020 vs. 2060 (Million)
5.2.1.3 Growing Usage of Home-Based Lateral Flow Assay Devices
5.2.1.4 Growing Demand for Point-Of-Care Testing
5.2.1.5 Need for Rapid Diagnostic Testing for COVID-19
Figure 25 Number of Confirmed Cases of COVID-19, by Who Region (Million)
5.2.2 Restraints
5.2.2.1 Inconsistent Results of Lateral Flow Assay Tests
5.2.3 Opportunities
5.2.3.1 Evolving Applications of Lateral Flow Assays
Table 3 List of Commercially Available Saliva LFA Products
5.2.3.2 Rising Demand for Lateral Flow Assays in the Food & Beverage Industry
5.2.4 Challenges
5.2.4.1 Limited Reimbursements for Lateral Flow Assay Products
5.2.4.2 Difficulties in Procuring Quality Raw Materials for the Development of Lateral Flow Assay Tests
5.3 COVID-19 Economic Assessment
5.4 Assessment of the Impact of COVID-19 on the Economic Scenario
Figure 26 Criteria Impacting the Global Economy
5.5 Assessment of the Impact of COVID-19 on the Economic Scenario in the Lateral Flow Assays Market
5.6 Trends/Disruptions Impacting Customers’ Businesses (YC-YCC) in Lateral Flow Assays Market
Figure 27 YC-YCC Shift in Lateral Flow Assays Market
5.7 Average Selling Price Trend
Table 4 Average Selling Price of Lateral Flow Analyzers, by Region, 2020
Table 5 Average Selling Price of Lateral Flow Assays (Kits & Reagents)
5.8 Ecosystem Market Map
Figure 28 Ecosystem: Lateral Flow Assays Market (2020)
5.9 Patent Analysis
5.9.1 Patent Publication Trends for Lateral Flow Assay
Figure 29 Global Patent Publication Trends in the Lateral Flow Assays Market, 2016-2021
5.9.2 Top Applicants (Companies) of Lateral Flow Assays Patents
Figure 30 Top Companies That Applied for Lateral Flow Assays Patents, 2016-2021
5.9.3 Jurisdiction Analysis: Top Applicants (Countries) for Patents in Lateral Flow Assays Market
Figure 31 Jurisdiction Analysis: Top Applicant Countries for Lateral Flow Assays Patents, 2016-2021
5.10 Value Chain Analysis
Figure 32 Lateral Flow Assays Market: Value Chain Analysis (2020)
5.11 Technology Analysis
5.11.1 Key Technology: Lateral Flow Assays
5.11.2 Adjacent Technology: Elisa (Enzyme-Linked Immunosorbent Assays)
5.12 Case Study Analysis
5.13 Regulatory Landscape
Table 6 Regulatory Standards/Approvals Required for Lateral Flow Immunoassay Products, by Country/Region
5.13.1 North America
5.13.2 Europe
5.13.3 Asia
5.13.3.1 India
5.13.3.2 China
5.13.3.3 Japan
5.14 Porter's Five Forces Analysis
Table 7 Lateral Flow Assays Market: Porter's Five Forces Analysis
5.14.1 Threat from New Entrants
5.14.2 Threat from Substitutes
5.14.3 Bargaining Power of Suppliers
5.14.4 Bargaining Power of Buyers
5.14.5 Intensity of Competitive Rivalry
5.15 Adjacent Market Analysis


6 Lateral Flow Assays Market, by Product
6.1 Introduction
Table 8 Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
6.2 Kits & Reagents
6.2.1 Increasing Demand for POC Testing is Driving the Demand for Kits & Reagents in the Lateral Flow Assays Market
Table 9 Lateral Flow Kits & Reagents Market, by Country, 2019-2026 (USD Million)
6.3 Lateral Flow Assays Readers Market
Table 10 Examples of Lateral Flow Readers Available in the Market
Table 11 Lateral Flow Assay Kits & Reagents: with and Without Analyzers
Table 12 Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 13 Lateral Flow Readers Market, by Application, 2019-2026 (USD Million)
Table 14 Lateral Flow Readers Market, by End-user, 2019-2026 (USD Million)
Table 15 Lateral Flow Readers Market, by Country, 2019-2026 (USD Million)
6.3.1 Digital/Handheld Readers
6.3.1.1 Technological Advancements and High Accuracy are the Major Factors Driving the Growth of the Digital/Handheld Readers Market
Table 16 Digital/Handheld Lateral Flow Readers Market, by Country, 2019-2026 (USD Million)
Table 17 Digital/Handheld Lateral Flow Readers Market, by Region, 2019-2026 (Thousand Units)
6.3.2 Benchtop Readers
6.3.2.1 Lower Diagnosis Cost Per Patient is Driving the Benchtop Readers Market
Table 18 Benchtop Lateral Flow Readers Market, by Country, 2019-2026 (USD Million)
Table 19 Benchtop Lateral Flow Readers Volume, Region, 2019-2026 (Thousand Units)
6.4 Insights on Disposable and Reusable Lateral Flow Assay Readers
6.5 Lateral Flow Assays Readers Markets for Clinical Diagnostics Applications, by Type
6.5.1 Product Portfolio Analysis of Lateral Flow Assays Readers for Clinical Diagnostics Application
Table 20 Product Portfolio Analysis of Lateral Flow Assays Readers for Clinical Diagnostics Application
Figure 33 Product Portfolio Analysis of Lateral Flow Assays Readers for Clinical Diagnostics (2020)


7 Lateral Flow Assays Market, by Application
7.1 Introduction
Table 21 Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
7.2 Clinical Testing
Table 22 Lateral Flow Assays Market for Clinical Testing, by Type, 2019-2026 (USD Million)
Table 23 Lateral Flow Assays Market for Clinical Testing, by Country, 2019-2026 (USD Million)
7.2.1 Infectious Disease Testing
Table 24 Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 25 Lateral Flow Assays Market for Infectious Disease Testing, by Country, 2019-2026 (USD Million)
7.2.1.1 Mosquito-Borne Diseases
7.2.1.1.1 Increasing Incidence of Dengue is Driving the Growth of the Lateral Flow Assays Market for Mosquito-Borne Diseases
Table 26 Major Products: Dengue Testing
Table 27 Lateral Flow Assays Market for Mosquito-Borne Diseases, by Country, 2019-2026 (USD Million)
7.2.1.2 COVID-19
7.2.1.2.1 The Ongoing COVID-19 Pandemic to Drive the Demand for Rapid Lateral Flow Tests
Table 28 COVID-19 (Antigen and Antibody) Lateral Flow Assay Tests
Table 29 Lateral Flow Assays Market for COVID-19, by Country, 2019-2026 (USD Million)
7.2.1.3 Influenza
7.2.1.3.1 Growing Prevalence of Influenza Globally is Expected to Boost Market Growth
Table 30 Lateral Flow Assays Market for Influenza, by Country, 2019-2026 (USD Million)
7.2.1.4 Sexually Transmitted Infections
Table 31 Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 32 Lateral Flow Assays Market for Sexually Transmitted Infections, by Country, 2019-2026 (USD Million)
7.2.1.4.1 HIV
7.2.1.4.1.1 Growing Awareness About HIV POC Testing is One of the Major Factors Driving Market Growth
Table 33 Lateral Flow Assays Market for HIV, by Country, 2019-2026 (USD Million)
7.2.1.4.2 HPV
7.2.1.4.2.1 Rising Adoption of HPV Testing to Drive the Market During the Forecast Period
Table 34 Lateral Flow Assays Market for HPV, by Country, 2019-2026 (USD Million)
7.2.1.4.3 Chlamydia
7.2.1.4.3.1 Growing Incidence of Chlamydia and Rising Awareness Among Patients Drive Market Growth
Table 35 Lateral Flow Assays Market for Chlamydia, by Country, 2019-2026
7.2.1.4.4 Gonorrhea
7.2.1.4.4.1 Rising Incidence of Gonorrhea Globally and Increased Funding for R&D to Drive the Lateral Flow Assays Market During the Forecast Period
Table 36 Lateral Flow Assays Market for Gonorrhea, by Country, 2019-2026 (USD Million)
7.2.1.4.5 Syphilis
7.2.1.4.5.1 Growing Adoption of Novel Technologies Supporting the Growth of the Lateral Flow Assays Market for Syphilis Testing
Table 37 Lateral Flow Assays Market for Syphilis, by Country, 2019-2026 (USD Million)
7.2.1.4.6 Other Sexually Transmitted Infections
Table 38 Lateral Flow Assays Market for Other Sexually Transmitted Infections, by Country, 2019-2026 (USD Million)
7.2.1.5 Hepatitis
7.2.1.5.1 Nucleic Acid Hybridization-Based Lateral Flow Assays Hold Great Potential in the Hepatitis Testing Market
Table 39 Lateral Flow Assays Market for Hepatitis, by Country, 2019-2026 (USD Million)
7.2.1.6 Tuberculosis
7.2.1.6.1 Rising Prevalence and Growing Focus on Early Diagnosis and Treatment Drive the Market
Table 40 Lateral Flow Assays Market for Tuberculosis, by Country, 2019-2026 (USD Million)
7.2.1.7 Other Infectious Diseases
Table 41 Lateral Flow Assays Market for Other Infectious Diseases, by Country, 2019-2026 (USD Million)
7.2.2 Cardiac Marker Testing
Table 42 Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 43 Lateral Flow Assays Market for Cardiac Marker Testing, by Country, 2019-2026 (USD Million)
7.2.2.1 Troponin I & T
7.2.2.1.1 Introduction of High-Sensitivity Troponin Assays to Drive this Market During the Forecast Period
Table 44 Lateral Flow Assays Market for Troponin I & T Testing, by Country, 2019-2026 (USD Million)
7.2.2.2 CK-MB
7.2.2.2.1 Growing Applications of Lateral Flow Tests in Acute Myocardial Injuries to Drive this Market
Table 45 Lateral Flow Assays Market for CK-MB Testing, by Country, 2019-2026 (USD Million)
7.2.2.3 BNP and NT-proBNP
7.2.2.3.1 Increasing Demand for Cardiac Biomarker Tests to Detect Heart Stress and Damage to Drive Growth in this Market
Table 46 Lateral Flow Assays Market for BNP & NT-proBNP Testing, by Country, 2019-2026 (USD Million)
7.2.2.4 Myoglobin
7.2.2.4.1 Availability of New High-Sensitivity Cardiac Troponin Assays to Restrict the Growth of the Routine Myoglobin Testing Market
Table 47 Lateral Flow Assays Market for Myoglobin Testing, by Country, 2019-2026 (USD Million)
7.2.2.5 D-Dimer
7.2.2.5.1 Rising Incidence of Cardiovascular Diseases to Drive the Market for D-Dimer Tests
Table 48 Lateral Flow Assays Market for D-Dimer Testing, by Country, 2019-2026 (USD Million)
7.2.2.6 Other Cardiac Markers
Table 49 Lateral Flow Assays Market for Other Cardiac Marker Tests, by Country, 2019-2026 (USD Million)
7.2.3 Pregnancy & Fertility Testing
Table 50 Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 51 Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Country, 2019-2026 (USD Million)
7.2.3.1 Pregnancy Testing
7.2.3.1.1 Pregnancy Testing is Among the Most Common Application Areas for Lateral Flow Assays, Registering Slower Growth During the Forecast Period
Table 52 Lateral Flow Assays Market for Pregnancy Testing, by Country, 2019-2026 (USD Million)
7.2.3.2 Fertility Testing
7.2.3.2.1 Rising Infertility Rates Across the Globe Driving the Demand for POC Fertility Testing Kits
Table 53 Lateral Flow Assays Market for Fertility Testing, by Country, 2019-2026 (USD Million)
7.2.4 Cholesterol/Lipid Testing
7.2.4.1 Growing Prevalence of Obesity and CVD is the Key Factor Driving Market Growth
Table 54 Lateral Flow Assays Market for Cholesterol/Lipid Testing, by Country, 2019-2026 (USD Million)
7.2.5 Drugs-Of-Abuse Testing
7.2.5.1 Technological Advancements and Growing Focus on Workplace Drug Testing are Driving Market Growth
Table 55 Lateral Flow Assays Market for Drugs-Of-Abuse Testing, by Country, 2019-2026 (USD Million)
7.2.6 Other Clinical Tests
Table 56 Lateral Flow Assays Market for Other Clinical Tests, by Country, 2019-2026 (USD Million)
7.3 Veterinary Diagnostics
7.3.1 Infectious Disease Outbreaks (Particularly in Large Livestock Animals) to Drive Market Growth
Table 57 Lateral Flow Assays Market for Veterinary Diagnostics, by Country, 2019-2026 (USD Million)
7.4 Food Safety & Environment Testing
7.4.1 High Sensitivity and Ease of Use are Driving the Demand for Lateral Flow Assays for Food Safety Testing
Table 58 Lateral Flow Assays Market for Food Safety & Environmental Testing, by Country, 2019-2026 (USD Million)
7.5 Drug Development & Quality Testing
7.5.1 Increasing Focus on Product Safety and Quality Assurance is Driving the Growth of this Market
Table 59 Lateral Flow Assays Market for Drug Development & Quality Testing, by Country, 2019-2026 (USD Million)


8 Lateral Flow Assay Kits & Reagents Market, by Technique
8.1 Introduction
Table 60 Lateral Flow Assay Kits and Reagents Market, by Technique, 2019-2026 (USD Million)
8.2 Sandwich Assays
8.2.1 Wide Applications of Sandwich Assays in Clinical Testing Contribute to the Largest Share of this Segment
Table 61 Lateral Flow Sandwich Assays Market, by Country, 2019-2026 (USD Million)
8.3 Competitive Assays
8.3.1 Reduced Selectivity and Sensitivity of Competitive Assays in Relation to Sandwich Assays Could Hamper Growth
Table 62 Lateral Flow Competitive Assays Market, by Country, 2019-2026 (USD Million)
8.4 Multiplex Detection Assays
8.4.1 Increasing Adoption of Multi-Analyte Assays Among Clinicians to Drive the Growth of this Market
Table 63 Lateral Flow Multiplex Detection Assays Market, by Country, 2019-2026 (USD Million)


9 Lateral Flow Assays for Clinical Testing Market, by Sample Type
9.1 Introduction
Table 64 Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
9.2 Blood Samples
9.2.1 Increasing Use of Blood Samples for Infectious Disease Testing to Drive the Growth of this Segment
Table 65 Lateral Flow Assays Market for Blood Samples, by Country, 2019-2026 (USD Million)
9.3 Urine Samples
9.3.1 Growing Use of Urine Samples for Pregnancy Testing and Drugs-Of-Abuse Testing to Drive the Growth of this Market
Table 66 Lateral Flow Assays Market for Urine Samples, by Country, 2019-2026 (USD Million)
9.4 Saliva Samples
9.4.1 Easy and Low-Cost Collection, Transport, and Analysis of Saliva Samples are the Key Factors Driving Market Growth
Table 67 Lateral Flow Assays Market for Saliva Samples, by Country, 2019-2026 (USD Million)
9.5 Other Samples
Table 68 Clinical Testing Lateral Flow Assays Market for Other Samples, by Country, 2019-2026 (USD Million)


10 Lateral Flow Assays Market, by End-user
10.1 Introduction
Table 69 Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
10.2 Hospitals & Clinics
10.2.1 Increasing Use of POC Tests Driving the Adoption of Lateral Flow Assays Among Hospitals & Clinics
Table 70 Lateral Flow Assays Market for Hospitals & Clinics, by Country, 2019-2026 (USD Million)
10.3 Diagnostic Laboratories
10.3.1 Laboratory Testing is Largely Preferred Over Professional Settings for Urine and Blood Testing - A Key Factor Driving Market Growth
Table 71 Lateral Flow Assays Market for Diagnostic Laboratories, by Country, 2019-2026 (USD Million)
10.4 Home Care Settings
10.4.1 Growing Acceptance of Remote Monitoring Driving the Growth of the Lateral Flow Assays Market for Home Care
Table 72 Lateral Flow Assays Market for Home Care Settings, by Country, 2019-2026 (USD Million)
10.5 Pharmaceutical & Biotechnology Companies
10.5.1 Increasing Focus on Product Safety to Drive the Use of Lateral Flow Assays Among Pharmaceutical & Biotech Companies
Table 73 Lateral Flow Assays Market for Pharmaceutical & Biotechnology Companies, by Country, 2019-2026 (USD Million)
10.6 Other End-users
Table 74 Lateral Flow Assays Market for Other End-users, by Country, 2019-2026 (USD Million)


11 Lateral Flow Assays Market, by Region
11.1 Introduction
Figure 34 US to Dominate the Lateral Flow Assays Market During the Forecast Period
Table 75 Lateral Flow Assays Market, by Region, 2019-2026 (USD Million)
11.2 North America
Table 76 North America: Macroeconomic Indicators
Figure 35 North America: Lateral Flow Assays Market Snapshot
Table 77 North America: Lateral Flow Assays Market, by Country, 2019-2026 (USD Million)
Table 78 North America: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 79 North America: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 80 North America: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 81 North America: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 82 North America: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 83 North America: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 84 North America: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 85 North America: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 86 North America: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 87 North America: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 88 North America: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.2.1 US
11.2.1.1 The US Accounts for the Largest Share of the Lateral Flow Assays Market in North America
Table 89 US: Macroeconomic Indicators
Table 90 US: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 91 US: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 92 US: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 93 US: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 94 US: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 95 US: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 96 US: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 97 US: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 98 US: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 99 US: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 100 US: Lateral Flow Assays Market, by End-user, 2019-2026 USD Million)
11.2.2 Canada
11.2.2.1 Availability of Research Funding and Implementation of Favorable Government Initiatives are Driving the Market in Canada
Table 101 Canada: Macroeconomic Indicators
Table 102 Canada: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 103 Canada: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 104 Canada: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 105 Canada: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 106 Canada: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 107 Canada: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 108 Canada: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 109 Canada: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 110 Canada: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 111 Canada: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 112 Canada: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.3 Europe
Figure 36 Europe: Lateral Flow Assays Market Snapshot
Table 113 Europe: Lateral Flow Assays Market, by Country, 2019-2026 (USD Million)
Table 114 Europe: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 115 Europe: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 116 Europe: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 117 Europe: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 118 Europe: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 119 Europe: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 120 Europe: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 121 Europe: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 122 Europe: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 123 Europe: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 124 Europe: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.3.1 Germany
11.3.1.1 Growing Number of POC Diagnostics Centers to Drive the Demand for Lateral Flow Assays in Germany
Table 125 Germany: Macroeconomic Indicators
Table 126 Germany: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 127 Germany: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 128 Germany: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 129 Germany: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 130 Germany: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 131 Germany: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 132 Germany: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 133 Germany: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 134 Germany: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 135 Germany: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 136 Germany: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.3.2 France
11.3.2.1 High Prevalence of Age-Related Chronic Diseases and Infectious Diseases to Drive Market Growth in France
Table 137 France: Macroeconomic Indicators
Table 138 France: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 139 France: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 140 France: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 141 France: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 142 France: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 143 France: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 144 France: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 145 France: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 146 France: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 147 France: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 148 France: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.3.3 UK
11.3.3.1 Increasing Incidence of Chronic Diseases and Rising Prevalence of Obesity Propelling the Market Growth in the UK
Table 149 UK: Macroeconomic Indicators
Table 150 UK: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 151 UK: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 152 UK: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 153 UK: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 154 UK: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 155 UK: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 156 UK: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 157 UK: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 158 UK: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 159 UK: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 160 UK: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.3.4 Italy
11.3.4.1 Growing Initiatives Towards the Decentralization of Medical Services in Italy are Contributing to Market Growth
Table 161 Italy: Macroeconomic Indicators
Table 162 Italy: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 163 Italy: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 164 Italy: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 165 Italy: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 166 Italy: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 167 Italy: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 168 Italy: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 169 Italy: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 170 Italy: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 171 Italy: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 172 Italy: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.3.5 Spain
11.3.5.1 Increasing Focus of International Organizations and Domestic Players on the Development of POC Products in the Country to Drive Market Growth
Table 173 Spain: Macroeconomic Indicators
Table 174 Spain: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 175 Spain: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 176 Spain: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 177 Spain: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 178 Spain: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 179 Spain: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 180 Spain: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 181 Spain: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 182 Spain: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 183 Spain: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 184 Spain: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.3.6 Rest of Europe
Table 185 RoE: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 186 RoE: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 187 RoE: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 188 RoE: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 189 RoE: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 190 RoE: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 191 RoE: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 192 RoE: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 193 RoE: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 194 RoE: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 195 RoE: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.4 Asia-Pacific
Figure 37 Asia-Pacific: Lateral Flow Assays Market Snapshot
Table 196 APAC: Lateral Flow Assays Market, by Country, 2019-2026 (USD Million)
Table 197 APAC: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 198 APAC: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 199 APAC: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 200 APAC: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 201 APAC: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 202 APAC: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 203 APAC: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 204 APAC: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 205 APAC: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 206 APAC: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 207 APAC: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.4.1 Japan
11.4.1.1 Increasing Prevalence of Age-Related Illnesses Driving the Growth of the Lateral Flow Assays Market in Japan
Table 208 Japan: Macroeconomic Indicators
Table 209 Japan: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 210 Japan: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 211 Japan: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 212 Japan: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 213 Japan: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 214 Japan: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 215 Japan: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 216 Japan: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 217 Japan: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 218 Japan: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 219 Japan: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.4.2 China
11.4.2.1 Growing Adoption of Lateral Flow Assays in Veterinary Diagnostics and Drug Development is Expected to Drive Market Growth in China
Table 220 China: Macroeconomic Indicators
Table 221 China: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 222 China: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 223 China: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 224 China: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 225 China: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 226 China: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 227 China: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 228 China: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 229 China: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 230 China: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 231 China: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.4.3 India
11.4.3.1 Increasing Prevalence of Chronic Disorders, Growing Healthcare Concerns, and Rising Income Levels to Propel the Growth of this Market
Table 232 India: Macroeconomic Indicators
Table 233 India: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 234 India: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 235 India: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 236 India: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 237 India: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 238 India: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 239 India: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 240 India: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 241 India: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 242 India: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 243 India: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.4.4 Australia
11.4.4.1 Increasing Prevalence of Infectious Diseases, Especially Influenza, to Drive the Growth of the Lateral Flow Assays Market
Table 244 Australia: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 245 Australia: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 246 Australia: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 247 Australia: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 248 Australia: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 249 Australia: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 250 Australia: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 251 Australia: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 252 Australia: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 253 Australia: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 254 Australia: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.4.5 Rest of Asia-Pacific
Table 255 RoAPAC: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 256 RoAPAC: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 257 RoAPAC: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 258 RoAPAC: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 259 RoAPAC: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 260 RoAPAC: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 261 RoAPAC: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 262 RoAPAC: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 263 RoAPAC: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 264 RoAPAC: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 265 RoAPAC: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.5 Latin America
Table 266 Latin America: Lateral Flow Assays Market, by Country, 2019-2026 (USD Million)
Table 267 Latin America: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 268 Latin America: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 269 Latin America: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 270 Latin America: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 271 Latin America: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 272 Latin America: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 273 Latin America: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 274 Latin America: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 275 Latin America: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 276 Latin America: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 277 Latin America: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.5.1 Brazil
11.5.1.1 High Private Healthcare Expenditure and Increasing Geriatric Population Driving the Growth of the Lateral Flow Assays Market in the Country
Table 278 Brazil: Macroeconomic Indicators
Table 279 Brazil: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 280 Brazil: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 281 Brazil: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 282 Brazil: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 283 Brazil: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 284 Brazil: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 285 Brazil: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 286 Brazil: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 287 Brazil: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 288 Brazil: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 289 Brazil: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.5.2 Mexico
11.5.2.1 High Prevalence of Obesity and Related Chronic Diseases to Boost the Growth of the Lateral Flow Assays Market in the Forecast Period
Table 290 Mexico: Macroeconomic Indicators
Table 291 Mexico: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 292 Mexico: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 293 Mexico: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 294 Mexico: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 295 Mexico: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 296 Mexico: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 297 Mexico: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 298 Mexico: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 299 Mexico: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 300 Mexico: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 301 Mexico: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.5.3 Rest of Latin America
Table 302 RoLATAM: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 303 RoLATAM: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 304 RoLATAM: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 305 RoLATAM: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 306 RoLATAM: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 307 RoLATAM: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 308 RoLATAM: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2019-2026 (USD Million)
Table 309 RoLATAM: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 310 RoLATAM: Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 311 RoLATAM: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 312 RoLATAM: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)
11.6 Middle East & Africa
11.6.1 Significant Support from Governments and Global Firms Towards Expansion of Healthcare Services is Driving the Adoption of Lateral Flow Assays
Table 313 Africa: Macroeconomic Indicators
Table 314 Middle East & Africa: Lateral Flow Assays Market, by Product, 2019-2026 (USD Million)
Table 315 Middle East & Africa: Lateral Flow Readers Market, by Type, 2019-2026 (USD Million)
Table 316 Middle East & Africa: Lateral Flow Assays Market, by Application, 2019-2026 (USD Million)
Table 317 Middle East & Africa: Lateral Flow Assays Market for Clinical Testing Applications, by Type, 2019-2026 (USD Million)
Table 318 Middle East & Africa: Lateral Flow Assays Market for Infectious Disease Testing, by Disease Type, 2019-2026 (USD Million)
Table 319 Middle East & Africa: Lateral Flow Assays Market for Sexually Transmitted Infections, by Type, 2019-2026 (USD Million)
Table 320 Middle East & Africa: Lateral Flow Assays Market for Cardiac Marker Testing, by Type, 2029-2026 (USD Million)
Table 321 Middle East & Africa: Lateral Flow Assays Market for Pregnancy & Fertility Testing, by Type, 2019-2026 (USD Million)
Table 322 Middle East & Africa Lateral Flow Assay Kits & Reagents Market, by Technique, 2019-2026 (USD Million)
Table 323 Middle East & Africa: Lateral Flow Assays Market, by Sample Type, 2019-2026 (USD Million)
Table 324 Middle East & Africa: Lateral Flow Assays Market, by End-user, 2019-2026 (USD Million)


12 Competitive Landscape
12.1 Overview
12.2 Key Player Strategies/Right to Win
Figure 38 Overview of Strategies Adopted by Major Players in the Lateral Flow Assays Market
12.3 Revenue Share Analysis for Key Players in the Lateral Flow Assays Market
Figure 39 Revenue Share Analysis for the Key Players in the Lateral Flow Assays Market
12.4 Market Share Analysis
Figure 40 Lateral Flow Assays Market Share Analysis, by Key Player (2020)
Table 325 Lateral Flow Assays Market: Degree of Competition
12.5 R&D Assessment of Key Players
Figure 41 R&D Expenditure: Major Players in the Lateral Flow Assays Market, 2018 vs. 2020
12.6 Geographic Revenue Assessment of Key Players
Figure 42 Geographic Revenue Assessment: Lateral Flow Assays Market (2020)
12.7 Company Evaluation Quadrant
12.7.1 Stars
12.7.2 Pervasive Players
12.7.3 Emerging Leaders
12.7.4 Participants
Figure 43 Lateral Flow Assays Market: Company Evaluation Matrix, 2020
12.8 Company Evaluation Quadrant for SMEs & Start-Ups
12.8.1 Progressive Companies
12.8.2 Dynamic Companies
12.8.3 Starting Blocks
12.8.4 Responsive Companies
Figure 44 Lateral Flow Assays Market: Company Evaluation Matrix for SMEs & Start-Ups
12.9 Competitive Benchmarking
12.9.1 Overall Company Footprint
Table 326 Overall Company Footprint (25 Companies)
Table 327 Company Footprint: by Product (25 Companies)
Table 328 Company Footprint: by Technique (25 Companies)
Table 329 Company Footprint: by Application (25 Companies)
Table 330 Company Footprint: by Sample Type (25 Companies)
Table 331 Company Footprint: by End-user (25 Companies)
Table 332 Company Footprint: by Region (25 Companies)
12.1 Competitive Scenario
12.10.1 Product Launches & Approvals
Table 333 Product Launches & Approvals, January 2018-September 2021
12.10.2 Deals
Table 334 Deals, January 2018-September 2021
12.10.3 Expansions
Table 335 Expansions, January 2018-September 2021


13 Company Profiles
13.1 Key Players
(Business Overview, Solutions Offered, Recent Developments, COVID-19 Related Developments, Analyst's View, Key Strengths/Right to Win, Strategic Choices, Weaknesses and Competitive Threats)*
13.1.1 Abbott Laboratories
Table 336 Abbott Laboratories: Business Overview
Figure 45 Abbott Laboratories: Company Snapshot (2020)
13.1.2 F. Hoffmann-La Roche AG
Table 337 F. Hoffmann-La Roche AG: Business Overview
Figure 46 F. Hoffmann-La Roche AG: Company Snapshot (2020)
13.1.3 Quidel Corporation
Table 338 Quidel Corporation: Business Overview
Figure 47 Quidel Corporation: Company Snapshot (2020)
13.1.4 Danaher Corporation
Table 339 Danaher Corporation: Business Overview
Figure 48 Danaher Corporation: Company Snapshot (2020)
13.1.5 Siemens AG
Table 340 Siemens AG: Business Overview
Figure 49 Siemens AG: Company Snapshot (2020)
13.1.6 Becton, Dickinson and Company
Table 341 Becton, Dickinson and Company: Business Overview
Figure 50 Becton, Dickinson and Company: Company Snapshot (2020)
13.1.7 bioMérieux SA
Table 342 bioMérieux SA: Business Overview
Figure 51 bioMérieux SA: Company Snapshot (2020)
13.1.8 Bio-Rad Laboratories, Inc.
Table 343 Bio-Rad Laboratories, Inc.: Business Overview
Figure 52 Bio-Rad Laboratories, Inc.: Company Snapshot (2020)
13.1.9 Thermo Fisher Scientific Inc.
Table 344 Thermo Fisher Scientific, Inc.: Business Overview
Figure 53 Thermo Fisher Scientific, Inc.: Company Snapshot (2020)
13.1.10 Perkinelmer Inc.
Table 345 Perkinelmer, Inc.: Business Overview
Figure 54 Perkinelmer, Inc.: Company Snapshot (2020)
13.2 Other Players
13.2.1 Qiagen N.V.
Table 346 Qiagen N.V.: Business Overview
Figure 55 Qiagen N.V.: Company Snapshot (2020)
13.2.2 Merck KGaA
Table 347 Merck KGaA: Business Overview
Figure 56 Merck KGaA: Company Snapshot (2020)
13.2.3 Hologic, Inc.
Table 348 Hologic, Inc.: Business Overview
Figure 57 Hologic, Inc.: Company Snapshot (2020)
13.2.4 Abcam plc
Table 349 Abcam plc: Business Overview
Figure 58 Abcam plc: Company Snapshot (2020)
13.2.5 Surmodics IVD
Table 350 Surmodics IVD: Business Overview
Figure 59 Surmodics IVD.: Company Snapshot (2020)
13.2.6 Chembio Diagnostic Systems, Inc.
Table 351 Chembio Diagnostics Systems: Business Overview
Figure 60 Chembio Diagnostic Systems, Inc.: Company Snapshot (2020)
13.2.7 Orasure Technologies
Table 352 Orasure Technologies: Business Overview
Figure 61 Orasure Technologies: Company Snapshot (2020)
13.2.8 DCN Diagnostics
Table 353 DCN Diagnostics: Business Overview
13.2.9 Polysciences, Inc.
Table 354 Polysciences, Inc.: Business Overview
13.2.10 Abingdon Health
Table 355 Abingdon Health: Business Overview
13.2.11 Bioporto Diagnostics A/S
Table 356 Bioporto Diagnostics A/S: Business Overview
Figure 62 Bioporto Diagnostics A/S: Company Snapshot (2020)
13.2.12 Microcoat Biotechnologies GmbH
Table 357 Microcoat Biotechnologies GmbH: Business Overview
13.2.13 Scienion AG
Table 358 Scienion AG: Business Overview
13.2.14 Senova GmbH
Table 359 Senova GmbH: Business Overview
13.2.15 Access Bio, Inc.
Table 360 Access Bio, Inc.: Business Overview
*Business Overview, Solutions Offered, Recent Developments, COVID-19 Related Developments, Analyst's View, Key Strengths/Right to Win, Strategic Choices, Weaknesses and Competitive Threats Might Not be Captured in Case of Unlisted Companies


14 Appendix
14.1 Discussion Guide
14.2 KnowledgeStore: The Subscription Portal
14.3 Available Customizations


Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Abcam plc
  • Abingdon Health
  • Access Bio, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Bioporto Diagnostics A/S
  • Chembio Diagnostic Systems, Inc.
  • Danaher Corporation
  • DCN Diagnostics
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Merck KGaA
  • Microcoat Biotechnologies GmbH
  • Orasure Technologies
  • Perkinelmer Inc.
  • Polysciences, Inc.
  • Qiagen N.V.
  • Quidel Corporation
  • Scienion AG
  • Senova GmbH
  • Siemens AG
  • Surmodics IVD
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...